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http://dxObjectives: We sought to explore and create a reliable, convenient, and economic hyperkinetic pulmonary
artery hypertension (PAH) model and confirm the exact time of establishing a reversible or irreversible model
to serve as a platform for future studies.
Methods: We used a common carotid artery and jugular vein shunt with an anastomosis and cuff to create a
hyperkinetic PAH model in rabbits. At 1, 2, 3, 6, and 12 months postoperatively, the systolic pressure, mean
pulmonary arterial pressure, and mean arterial pressure were measured by catheterization and the right ventricle
hypertrophy index was calculated. Pathologic changes in the small pulmonary arteries were observed with
hematoxylin and eosin staining, and the Heath-Edwards classification system was used to evaluate PAH.
Results: The anastomosis and cuff graft groups both increased in systolic pressure, mean pulmonary arterial
pressure (P<.05), and right ventricle hypertrophy index (P<.05). However, the anastomosis method resulted
in a lower mortality rate, greater patency, and overall success rate compared with the cuff graft method (P<.05).
Furthermore, from the observed pathologic changes and the Heath-Edwards classification system, a reversible
and an irreversible PAH model was established at 3 and 6 months postoperatively, respectively.
Conclusions: The common carotid artery and jugular vein anastomosis method is a stable hyperkinetic PAH
model in rabbits. Reversible and irreversible PAH models were established at 3 and 6 months postoperatively,
respectively. (J Thorac Cardiovasc Surg 2014;148:2353-9)E
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SPulmonary arterial hypertension (PAH) is a clinical patho-
physiologic syndrome characterized by a progressively
increased pulmonary vascular resistance that can be caused
by heterogeneous disease and/or other pathologic abnor-
malities. The clinical manifestations include increased right
ventricular afterload, decreased activity intolerance, and
eventual death resulting from right heart failure.1,2 PAH is
characterized by pulmonary vasoconstriction, aberrant
proliferation of smooth muscle and endothelial cells,
and, later, irreversible increased pulmonary vascular
resistance.3 However, the etiology of PAH is not completely
understood.
PAH is a significant contributor to the morbidity andmor-
tality in patients with congenital heart disease, especially in
those with Eisenmenger syndrome.4 Thus, it is imperative
to establish a pulmonary arterial hypertension model to
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The Journal of Thoracic and Carto induce PAH, including subcutaneous injection of mono-
crotaline,5-7 chronic hypoxia,8,9 gene knockouts,10 vascular
endothelial growth factor receptor blockade,11 arteriove-
nous shunts,12 and other newer methods.13-16 However,
only arteriovenous shunt methods will result in the same
pathophysiologic changes present during congenital heart
disease in humans.
We have previously attempted to establish new methods
to mimic PAH in both rabbits and rodents, with limited suc-
cess.17,18 We first established a PAH model17 using a left
common carotid artery and pulmonary trunk anastomosis
in rabbits and later established another model,18 with a
left common carotid artery and left jugular vein shunt in a
cuff style in Wistar rats. However, the first model was
complicated and required thoracotomy, which has a poten-
tially high mortality rate. However, the long-term patency
rate of the second model was questionable. Furthermore,
the exact period required to successfully establish an irre-
versible PAH model after arteriovenous shunt was un-
known. PAH results in pathologic changes that are
initially reversible but become irreversible. Thus, when a
PAHmodel has been established, it is essential to determine
the point at which both reversible and irreversible stages
occur to facilitate future studies that will more accurately
reflect PAH in humans.
Our goal was to establish a convenient, economic, highly
successful, and stable PAH model that better represents the
aberrant hemodynamic state in children with congenital
heart disease. We also sought to determine the point atdiovascular Surgery c Volume 148, Number 5 2353
Abbreviations and Acronyms
CJSA ¼ common carotid artery and jugular vein
shunt by anastomosis
CJSC ¼ common carotid artery and jugular vein
shunt by cuff style method
PAH ¼ pulmonary artery hypertension
RV ¼ right ventricle
LVþS ¼ left ventricle plus septum
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Swhich the reversible and irreversible stages of PAH occur to
facilitate the design of future studies.METHODS
Animals
A total 120 male New Zealand white rabbits (age, 4 weeks; weight, 545
 27 g) were provided by the Laboratory Animal Center of Shandong Uni-
versity. The rabbits received humane care, and the experiments were per-
formed in accordance with the guidelines of Animal Care and Use
Committee of Shandong University. The rabbits were housed individually
in a room at a constant ambient temperature and humidity with a 12-hour
light and dark cycle. After 10 days of acclimation, the 120 rabbits were
randomly assigned into the following 3 groups (40 rabbits each): group
1, common carotid artery and jugular vein shunt by anastomosis (CJSA);
group 2, common carotid artery and jugular vein shunt in cuff style method
(CJSC) group; and group 3, sham operation group.
Surgical Procedures
CJSA group. In the CJSA group of 40 rabbits, the rabbits were anes-
thetized with an intravenous injection of pentobarbital sodium (30 mg/kg).
Once the anesthesia took effect, a 3-cm midline incision was made in the
neck. The right external jugular vein was exposed and then injected with
1mg/kg heparin. The right common carotid artery and right internal jugular
vein were carefully dissected. The right common carotid artery was
clamped at the proximal site and ligated at the distal site. The right common
carotid artery was then amputated immediately before the bifurcation. Un-
der an operative microscope, a 2-mm hole was made in the right internal
jugular vein and an end-to-side anastomosis was made between the right
common carotid artery and the right internal jugular vein using Prolene
7-0 suture (Figures 1 and 2). The degree of anastomosis patency was tested
by releasing the vascular clamps to visualize the pulsative bright red blood
flow in the proximal site of the right internal jugular vein. Penicillin was
administered postoperatively to prevent secondary infection.
CJSC group. CJSC was performed in a fashion similar to that for the
CJSA group. However, the end-to-side shunt was made by a 5-mm-long
polyvinyl tube with a 2-mm external diameter and 1.8-mm internal
diameter. The carotid artery was inserted into the tube, and the intimal
side of the arterywas everted and ligated using a 2-0 thin thread. Finally, the
cuff-mounted carotid artery was inserted into the left jugular vein through
a 2-mm incision and ligated to connect these 2 vessels, endothelium to
endothelium18,19 (Figures 2 and 3).
Sham operation group. The vessels were isolated as detailed for
the CJSA and CJSC groups. The sham operation was performed by
isolating the vessels without an additional surgical procedure.
Aspirin (10 mg/kg/d) was administrated to the rabbits from all groups to
prevent coagulation that continued to the end of experimental period. Rab-
bits from each group were killed and evaluated 1, 2, 3, 6, and 12 months
after surgery. Data collected from the rabbits with failed shunts or those
that died of the surgery were excluded from additional analysis.2354 The Journal of Thoracic and Cardiovascular SurData Acquisition and Analysis
To detect shunt patency and overall cardiac function, echocardiography
was performed after anesthesia and before death. As stated, all the data
from rabbits that died as a result of surgery or had failed shunts (occluded
shunts or occluded anastomoses) were excluded.
The systolic pulmonary artery pressure, mean pulmonary artery pres-
sure, and mean arterial pressure were measured by catheterization. These
hemodynamic data were collected by first anesthetizing the rabbits and
exposing the left jugular vein. A 3F polyethylene catheter was then inserted
into the vein and advanced into the right ventricular and then the main pul-
monary artery under fluoroscopic guidance. In addition, the position of the
catheter was confirmed by transitional changes in the pressure curve dis-
played on the monitor. The systemic pressure was monitored by a second
catheter inserted into the left common carotid artery. Both of the catheters
were connected to a transducer, and the pulmonary arterial pressure and
systemic pressure were recorded. The hemodynamic data were recorded
before and after closure of the shunt vessels. The parameters were recorded
3 times for each rabbit, and the average pressure was calculated.
After collection of the hemodynamic data, the rabbits were killed by a
pentobarbital sodium overdose. The heart tissue was collected and sepa-
rated into right ventricle (RV) and left ventricle plus septum (LVþS).
The extent of right ventricular hypertrophy was evaluated by the ratio of
the RV mass to the LVþS mass.
The rabbit lungs were fixed in 4% paraformaldehyde in phosphate-
buffered saline for morphology analysis. The lungs were subjected to a
dehydration series, embedded in paraffin, and sectioned in 5-mm slices.
Next, the slices were stained with hematoxylin-eosin and examined under
an optical microscope (Olympus BX51, Olympus, Center Valley, Pa) to
assess the changes occurring in the small arteries.
Statistical Analysis
The operative time, hemodynamic data, and right ventricular hypertro-
phy data are expressed as the mean  standard deviation. The successful
rate was analyzed using the chi-square test. For rabbits with shunts, the
data collected before and after shunt closure were compared using Stu-
dent’s t tests. Analysis of variance was used to test for differences among
the CJSC, CJSA, and sham operation groups. The Statistical Package for
Social Sciences, version 17.0, for Windows (SPSS, Chicago, Ill), was
used for all statistical analyses.RESULTS
The mean operative time in the CJSC and CJSA groups
was 1.40  0.12 hours and 1.48  0.21 hours, respectively
(Table 1). No significant difference was found in the final
body weight. The mortality rate in the CJSC group (27.5%)
was greater than that in the CJSA group (12.5%). In the
CJSC group, 3 rabbits died of a common carotid artery injury,
6 died of cuff drop off and hemorrhagewithin 24 hours of sur-
gery, and 2 died of undefined complications (likely heart fail-
ure). In the CJSA group, 4 rabbits died of a common carotid
artery injury and uncontrolled bleeding, and only 1 died of
undefined complications. According to the echocardio-
graphic findings and the dissection before death, 7 of the 29
surviving rabbits in the CJSC group and 3 of 35 surviving
rabbits in the CJSA group presented with cuff occlusion.Pulmonary Hemodynamics
To exclude the influence of the anastomosis and cuff on
the pulmonary artery pressure, the pulmonary arterygery c November 2014
FIGURE 1. End-to-side anastomosis (C) between the right common
carotid artery (A) and right internal jugular vein (B).
FIGURE 3. Right common carotid artery (A) and right internal jugular
vein (B) shunt in cuff style (C).
Liu et al Evolving Technology/Basic Sciencepressure was measured before and after closure of the shunt
vessels. Compared with the sham operation group, the
CJSC and CJSA groups had a greater systolic pulmonary
arterial pressure and mean pulmonary arterial pressure
before closure. Although the pulmonary artery pressure
decreased after closure in the sham operation group
(Figure 4), the systolic pulmonary arterial pressure and
mean pulmonary arterial pressure were maintained at a
greater value in the CJSC and CJSA groups (P < .05;
Figure 5). When we compared the CJSC and CJSA groups,
no significant differences were observed.FIGURE 2. Drawing of surgical techniques and differences between (A)
common carotid artery and jugular vein shunt by cuff style method (CJSC)
and (B) common carotid artery and jugular vein shunt by anastomosis
(CJSA).
The Journal of Thoracic and CarRight Ventricular Hypertrophy
A significant elevation in the ratio of the RV mass to the
LVþS mass was found in the CJSC and CJSA groups
compared with the sham operation group (P < .05;
Figure 6). However, no differences were found between
the CJSC and CJSA groups.E
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The pathologic features of hypertensive pulmonary
vascular disease was classified according to the Heath-
Edwards classification system20 (Table 2).Within 3months,
the rabbit lung microvascular vessel in the CJSA and CJSC
groups demonstrated uniform intimal thickening and
medial hypertrophy, with degeneration, swelling, hyperpla-
sia, and fibrosis of nonmuscular arterial endothelial cells.
Furthermore, these groups had developed smooth muscle
tissue and hyperplasia of the elastic collagen fibers (grade
I-II) in the tunica media (Figure 7, B). Moreover, a severe
narrowing or occlusion of the lumen was frequently found
in the CJSC (4 of 22) and CJSA (11 of 32) groups (grade
III; Figure 7, C). By 3 months, 2 of 12 in the CJSC group
and 4 of 20 in the CJSA group demonstrated plexiform
lesions in the lung microvascular vessels (grade IV-VI),
which marked an irreversible pathologic changeTABLE 1. Operative time and success rate
Group Rabbits
Operative
time (h) Died (n) Occlusion (n)
Success
rate (%)
CJSC 40 1.40  0.12 11 7 55
CJSA 40 1.48  0.21 5 3 80*
No significant difference was found in operative time, and the CJSA group had a
greater success rate than the CJSC group. CJSC, Common carotid artery and jugular
vein shunt by cuff style method; CJSA, common carotid artery and jugular vein shunt
by anastomosis. *P<.05 versus CJSC group.
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FIGURE 4. Systolic pulmonary arterial pressure (SPAP) before and after closure of shunt vessels in (A) the common carotid artery and jugular vein shunt
by cuff style method (CJSC) group and (B) the common carotid artery and jugular vein shunt by anastomosis (CJSA) group. In the CJSC group, the SPAP
before closure was greater than that after closure in 1 month, with no significant difference after 2 months (*P<.05). In the CJSA group, the SPAP before
closure was greater than that after closure at 1 and 2 months, with no significant difference after 3 months (*P<.05).
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occur in human PAH. However, no such pathologic changes
were seen before 3 months in either group.FIGURE 5. The systolic pulmonary arterial pressure (SPAP), mean pulmonary
shunt vessels. A and B, Compared with the sham operation group, the common c
common carotid artery and jugular vein shunt by anastomosis (CJSA) group sh
months preoperatively and remained steady from 6 to 12months (*P<.05). C, C
in the MAP between the CJSC and CJSA groups.
2356 The Journal of Thoracic and Cardiovascular SurDISCUSSION
In the present report, we have described 2 reliable hyper-
kinetic PAH models in rabbits. The hemodynamic data,arterial pressure (MPAP), and mean arterial pressure (MAP) after closure of
arotid artery and jugular vein shunt by cuff style method (CJSC) group and
owed greater SPAP and MPAP. Both SPAP and MPAP were increased at 6
ompared with the sham operation group, no significant differencewas found
gery c November 2014
FIGURE 6. Right ventricular hypertrophy. Compared with the sham oper-
ation group, the common carotid artery and jugular vein shunt by cuff style
method (CJSC) group and common carotid artery and jugular vein shunt by
anastomosis (CJSA) group showed a greater ratio of the right ventricular
mass to the left ventricular plus septum mass (RV/LVþS) (*P<.05).
Liu et al Evolving Technology/Basic Scienceright ventricular hypertrophy index (ratio of the RV mass to
the LVþS mass), echocardiographic findings, and histo-
pathologic findings were compared between the 2 models.
Because the mortality and patency rate are significant influ-
encing factors in establishing a successful model, these 2
factors were also evaluated. Additionally, we examined
and characterized the histopathologic changes that mediate
the transition from reversible to irreversible stages of PAH.
We successfully determined the period that elapsed before
establishing an irreversible model.TABLE 2. Number of rabbits according to Heath-Edwards
classification
Postoperative point
at which rabbits were
killed (no. killed) Grade I-II Grade III Grade IV-VI
CJSC
1 mo (5) 5 0 0
2 mo (5) 5 0 0
3 mo (4) 3 1 0
6 mo (4) 2 1 1
12 mo (4) 1 2 1
CJSA
1 mo (6) 6 0 0
2 mo (6) 5 1 0
3 mo (7) 4 2 1
6 mo (6) 1 3 2
12 mo (7) 1 5 1
At 3 months and earlier postoperatively, all the rabbits in the CJSC group and all the
rabbits except for 1 in the CJSA group showed grade I-II pathologic changes that were
reversible, and 1 rabbit in the CJSA group showed grade III changes that were
between reversible and irreversible. After 3 months, 6 of 12 rabbits in the CJSC group
and 6 of 20 rabbits in the CJSA group had grade I-II changes. Finally, 4 of 12 rabbits in
the CJSC group and 10 of 20 rabbits in the CJSA group had grade III changes, and
plexiform lesions (grade IV-VI), indicating irreversible PAH, were demonstrated in
2 of 12 rabbits in the CJSC group and 4 of 20 rabbits in the CJSA group; no irrevers-
ible pathologic changes were noted before 3 months in either group. CJSC, Common
carotid artery and jugular vein shunt by cuff style method; CJSA, common carotid
artery and jugular vein shunt by anastomosis.
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PAH. However, many of these models have limitations
owing to surgical complications and difficulty, high mortal-
ity rates, and/or a failure to adequately mimic PAH in
humans, including a failure to determine the exact point
at which irreversible pathologic changes will occur. For
example, owing to the complex operation protocol and
high mortality rate, data from arteriovenous shunt models
(representing hyperkinetic PAH) have seldom been re-
ported. However, we confirmed in our earlier study17 that
a successful hyperkinetic rabbit PAH model could be estab-
lished using left common carotid artery and pulmonary
trunk anastomosis. However, that method required a thora-
cotomy, which frequently resulted in death. In addition, a
systemic-to-pulmonary artery shunt such as anastomosis
of the left common carotid artery to the pulmonary trunk
and others has resulted in a fairly high load to the pulmo-
nary artery and heart, with the animals, especially the
young, easily dying of heart failure. However, if the period
after surgery was short, the PAHmodel was probably estab-
lished unsuccessfully. Therefore, the success rate of that
model was low. In response, we attempted to establish a
novel hyperkinetic PAH model without thoracotomy and
found that the pathophysiologic and histopathologic
changes of the model were ultimately similar to those of
congenital heart disease. This model can now serve as a
platform for future PAH research, because it has both low
mortality and a high success rate and adequately reflects
the conditions present in humans.
Rats have also been commonly used for PAH models,
along with sheep and dogs.16,21 However, studies using
rabbits have rarely been reported. The blood vessels of
the rats are too fine to perform anastomosis, consequently
a shunt in a cuff style has typically been used.18,19 We
had previously established another PAH model using a
left common carotid artery and left jugular vein shunt in a
cuff style in Wistar rats; however, the long-term patency
rate was questionable.18 Sheep, dogs, and other large ani-
mals have blood vessels suitable for anastomosis, but space
and feeding constraints have made it difficult to house and
feed a sufficient quantity of these animals for statistical
analysis. In contrast, rabbits are excellent candidates for
anastomosis and require less space and food. Therefore,
our rabbit model will be a more economic model than those
that use larger animals (eg, sheep). We believe rabbits pro-
vide a more appropriate model for hyperkinetic PAH
research.
In our study, after 3 months, all the surviving rabbits with
successful arteriovenous shunts had reached the standard of
PAH.22 To exclude the influence of the arteriovenous shunt,
we measured the pulmonary artery pressure before and after
closure of the shunt vessels. We also found that the right
ventricular hypertrophy indexes of the 2 model groups
(CJSA and CJSC) were greater than those of the shamdiovascular Surgery c Volume 148, Number 5 2357
FIGURE 7. Pathologic changes in pulmonary artery postoperatively (hematoxylin-eosin stain, 3200). A, Sham operation group; B, grade I to II intimal
thickening and medial hypertrophy of arterioles; C, grade III advanced medial thickening and severe narrowing or occlusions of arterioles; and D, grade
IV-VI plexiform lesions of arterioles.
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that a successful common carotid artery and jugular vein
shunt was formed using either anastomosis or cuff tech-
niques that ultimately led to pathologic features consistent
with PAH.
It took longer to perform the arteriovenous anastomosis
than the arteriovenous shunt in the cuff procedure. The
longer operation time resulted from the general difficulty
in inosculating fine vessels. The total period from anes-
thesia induction to the end of the operation was about
1.40  0.12 hours in the CJSC group and 1.48  0.21
hours in the CJSA group. However, as the proficiency
with the anastomosis technique increased, the operative
time for the CJSA group became shorter. One of the
most important and difficult steps during both procedures
was isolating the artery. It was easily damaged, which
frequently led to bleeding. Some of the rabbits died
because of this. In the CJSC group, the thin thread used
to ligate the cuff could drop off easily, causing profuse
bleeding and, typically, death within 24 hours of surgery.
Therefore, the CJSC group had a greater mortality rate
than the CJSA group. In addition to a greater mortality
rate, the CJSC group had a lower patency rate. We would
suggest 2 possible explanations for this. One explanation
is that the internal diameter of cuff is not fit for the vessels
of all the rabbits, such that blood flows from the wide
vessel to the narrow cuff graft; thus, the wide vessel,
despite the administration of aspirin, begins to occlude2358 The Journal of Thoracic and Cardiovascular Surowing to thrombosis at the narrow site. Another possible
explanation is that the cuff graft is recognized by the
body as a foreign material, which can result in a chronic
inflammatory reaction that could also lead to occlusion.
Nonetheless, PAH was successfully formed 3 months post-
operatively in both groups. However, the cuff graft will
become relatively narrow owing to the growing artery.
This can cause occlusions in the CJSC group, as previously
described. In contrast, the arteriovenous anastomosis can
grow in the CJSA group, reducing the complications stem-
ming from differences in the vessel diameter of the individ-
ual rabbits.
To our knowledge, this is the first study to evaluate PAH
using the Heath-Edwards classification system20 in rabbits
at 1, 2, 3, 6, and 12months after surgery, monitoring the pul-
monary vascular pathologic changes as they progressed
from reversible to irreversible. Understanding the kinetics
of these changes will be indispensable in our future PAH
research. For instance, we could study rabbits within 3
months of surgery to use a PAH model whose pulmonary
vascular pathologic changes are reversible. This would be
suitable for studying the effect of certain drugs or cytokines
that might prevent or reverse vascular remodeling. In
contrast, if we choose to study PAH using angiogenesis,
we can work with animals 3 months after surgery, at
which time these changes will be permanent, allowing us
to exclude influencing factors that might affect vascular
remodeling.gery c November 2014
Liu et al Evolving Technology/Basic ScienceCONCLUSIONS
Hyperkinetic PAH can be established using a common
carotid artery and jugular vein shunt in rabbits. However,
the anastomosis method was superior to the cuff style
method, with a greater patency rate, lower mortality rate,
and greater overall success rate. Therefore, the CJSA
method can provide a reliable, convenient, economic, and
stable PAH model that represents the aberrant hemody-
namic state in children with congenital heart disease. We
can use this model to study the mechanisms of, and thera-
peutic approaches targeting, hyperkinetic PAH. In addition,
we have established the point at which reversible or irre-
versible pathologic changes occur, offering 2 distinct
models that can be selected according to the research direc-
tions in future studies on PAH.References
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